: 
Test Description
The Chlamydia Rapid Test (RDT) is a qualitative immunoassay designed for the rapid detection of Chlamydia trachomatis antigens in various specimen types, including female cervical swabs, male urethral swabs, and male urine. This test is crucial for diagnosing chlamydia infections, which are among the most common sexually transmitted infections globally. The test operates on a chromatographic principle, where the presence of Chlamydia antigens generates a visible color line on the test cassette, indicating a positive result.
Indications of the Test
The Chlamydia RDT is indicated for:
- Diagnosis of chlamydia infections in symptomatic and asymptomatic individuals.
- Screening in sexually active individuals, particularly in high-risk populations.
- Monitoring and follow-up of treatment effectiveness.
Patient Preparation/Instructions
Patients should follow these instructions prior to the test:
- Ensure proper specimen collection techniques to obtain adequate cellular material.
- For female patients, a cervical swab should be collected; for male patients, a urethral swab or urine specimen is appropriate.
- Avoid using any topical medications or vaginal products 24 hours before the test to minimize interference.
Typical Reference Values
- Positive Result: Indicates the presence of Chlamydia trachomatis antigens.
- Negative Result: Indicates the absence of detectable Chlamydia trachomatis antigens.
Turnaround Time
The results of the Chlamydia RDT are typically available within 10 to 15 minutes after the test is performed, allowing for prompt diagnosis and treatment initiation.
Order This Test
To order the Chlamydia RDT test, please click the ‘Order Test’ button and add it to your cart for processing.
